Parkinson disease trials in China

In China 102 Also abroad 823

102 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease
Where
Hong Kong
Age
18 years to 95 years
People
500 worldwide
Run by
Hong Kong University of Science and Technology
See details and how to joinNCT07381751
Early phase 1Not yet taking people in China
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations
Where
Hefei
Age
30 years to 70 years
People
18
Run by
Lingyi Biotech Co., Ltd.
See details and how to joinNCT07685444
Phase 1Taking people
Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
Where
Beijing
Age
30 years to 85 years
People
6
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT05901818
No phaseTaking people
Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application
Where
Fuzhou
Age
40 years to 80 years
People
700
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07679256
No phaseTaking people
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Where
Beijing
Age
30 years to 80 years
People
50
Run by
Peking University First Hospital
See details and how to joinNCT07570212
No phaseTaking people
Adaptive DBS for PD
Where
Beijing, Changsha, Chengdu, Guangzhou, Hefei, Jinan, Nanjing
Age
18 years and over
People
60
Run by
Beijing Pins Medical Co., Ltd
See details and how to joinNCT07635823
No phaseNot yet taking people in China
Immediate Effects of External Trigeminal Nerve Stimulation on Motor Dysfunction in Parkinson's Disease
Where
Xi'an
Age
40 years to 80 years
People
30
Run by
Zhengli Di
See details and how to joinNCT07656129
No phaseTaking people
Prospective Multicenter Registry Study of Multiple System Atrophy in China
Where
Beijing
Age
40 years to 75 years
People
214
Run by
Peking University First Hospital
See details and how to joinNCT07644013
Phase 4Not yet taking people in China
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Where
Wuhan
Age
50 years and over
People
44
Run by
YangPan
See details and how to joinNCT07384429
No phaseNot yet taking people in China
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
Where
Wuhan
Age
50 years and over
People
50
Run by
YangPan
See details and how to joinNCT07384442
No phaseNot yet taking people in China
Local Field Potential Correlates of Neuropsychiatric Symptoms in Parkinson's Disease
Where
Shanghai
Age
18 years to 75 years
People
20 worldwide
Run by
King's College London
See details and how to joinNCT07633379
No phaseTaking people
Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
Where
Shanghai
Age
50 years to 85 years
People
32
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07625540
No phaseNot yet taking people in China
A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History Study
Where
Fujian
People
3,000
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07588763
No phaseEnrolling by invitation
China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration
Where
Yantai
Age
55 years to 75 years
People
260
Run by
Yantai Yuhuangding Hospital
See details and how to joinNCT07586501
Phase 1/2Not yet taking people in China
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations
Where
Changsha
Age
30 years to 70 years
People
17
Run by
Shanghai Vitalgen BioPharma Co., Ltd.
See details and how to joinNCT07414290
Early phase 1Not yet taking people in China
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
Where
Zhejiang
Age
40 years to 70 years
People
6
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07533591
Phase 1Not yet taking people in China
Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery
Where
Hefei
Age
18 years to 70 years
People
10
Run by
iRegene Therapeutics Co., Ltd.
See details and how to joinNCT07550374
No phaseEnrolling by invitation
Intrapatient Comparison of STN and GPi tTIS in PD
Where
Shanghai
Age
50 years to 85 years
People
100
Run by
Ruijin Hospital
See details and how to joinNCT07018388
No phaseNot yet taking people in China
TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease
Where
Nanjing
Age
45 years to 65 years
People
75
Run by
Jiangsu Province Nanjing Brain Hospital
See details and how to joinNCT07480317
No phaseTaking people
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Where
Tianjin
Age
30 years to 85 years
People
700
Run by
Tianjin Huanhu Hospital
See details and how to joinNCT07386015
No phaseTaking people
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
Where
Shanghai
People
700
Run by
Ruijin Hospital
See details and how to joinNCT07353463
No phaseTaking people
SCAN Targeted Epidural Modulation for Parkinson's Disease
Where
Fuzhou
Age
40 years to 75 years
People
3
Run by
Changping Laboratory
See details and how to joinNCT06919822
No phaseEnrolling by invitation
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
Where
Suzhou
Age
40 years to 80 years
People
90
Run by
Second Affiliated Hospital of Soochow University
See details and how to joinNCT07176091
Phase 1Not yet taking people in China
Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease
Where
Hangzhou
Age
55 years to 75 years
People
12
Run by
iCamuno Biotherapeutics Ltd.
See details and how to joinNCT07212088
No phaseTaking people
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
Where
Beijing
Age
15 years to 75 years
People
720
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07392411